Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 436894, 10 pages
http://dx.doi.org/10.1155/2013/436894
Research Article

Differential Influence of Inositol Hexaphosphate on the Expression of Genes Encoding TGF-β Isoforms and Their Receptors in Intestinal Epithelial Cells Stimulated with Proinflammatory Agents

Department of Biochemistry, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland

Received 6 August 2013; Revised 8 November 2013; Accepted 27 November 2013

Academic Editor: Dennis Daniel Taub

Copyright © 2013 Małgorzata Kapral et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Baumgart and S. R. Carding, “Inflammatory bowel disease: cause and immunobiology,” The Lancet, vol. 369, no. 9573, pp. 1627–1640, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Böcker, O. Yezerskyy, P. Feick et al., “Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression,” International Journal of Colorectal Disease, vol. 18, no. 1, pp. 25–32, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. M. Al-Sadi and T. Y. Ma, “IL-1β causes an increase in intestinal epithelial tight junction permeability,” Journal of Immunology, vol. 178, no. 7, pp. 4641–4649, 2007. View at Google Scholar · View at Scopus
  4. M. Ligumsky, P. L. Simon, F. Karmeli et al., “Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease,” Gut, vol. 31, no. 6, pp. 686–689, 1990. View at Google Scholar · View at Scopus
  5. S. Hong, H.-J. Lee, S. J. Kim, and K.-B. Hahm, “Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-β signaling,” World Journal of Gastroenterology, vol. 16, no. 17, pp. 2080–2093, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. L. Elliott and G. C. Blobe, “Role of transforming growth factor beta in human cancer,” Journal of Clinical Oncology, vol. 23, no. 9, pp. 2078–2093, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Bierie and H. L. Moses, “Transforming growth factor beta (TGF-β) and inflammation in cancer,” Cytokine and Growth Factor Reviews, vol. 21, no. 1, pp. 49–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Paduch and P. Niedziela, “TGF-beta1 influence on TNF-alpha production and sTNF-Rs shedding in a coculture of colon carcinoma cell spheroids with normal cells,” In Vitro Cellular and Developmental Biology, vol. 45, no. 7, pp. 371–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Yang, Y. Pang, and H. L. Moses, “TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression,” Trends in Immunology, vol. 31, no. 6, pp. 220–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Kubiczkova, L. Sedlarikova, R. Hajek et al., “TGF-β—an excellent servant but a bad master,” Journal of Translational Medicine, vol. 10, pp. 183–207, 2012. View at Publisher · View at Google Scholar
  11. C.-H. Heldin, K. Miyazono, and P. Ten Dijke, “TGF-β signalling from cell membrane to nucleus through SMAD proteins,” Nature, vol. 390, no. 6659, pp. 465–471, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Moustakas and C.-H. Heldin, “The regulation of TGFβ signal transduction,” Development, vol. 136, no. 22, pp. 3699–3714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Bitzer, G. von Gersdorff, D. Liang et al., “A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA,” Genes and Development, vol. 14, no. 2, pp. 187–197, 2000. View at Google Scholar · View at Scopus
  14. A. Rizzo, M. J. Waldner, C. Stolfi et al., “Smad7 expression in T cells prevents colitis-associated cancer,” Cancer Research, vol. 71, no. 24, pp. 7423–7432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Massague, “TGFβ signalling in context,” Nature Reviews Molecular Cell Biology, vol. 13, no. 10, pp. 616–630, 2012. View at Google Scholar
  16. M. W. Saif and E. Chu, “Biology of colorectal cancer,” Cancer Journal, vol. 16, no. 3, pp. 196–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K.-B. Hahm, Y.-H. Im, T. W. Parks et al., “Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease,” Gut, vol. 49, no. 2, pp. 190–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. F. S. Santibañez, M. Quintanilla, and C. Bernabeu, “TGF-β/TGF-β receptor system and its role in physiological and pathological conditions,” Clinical Science, vol. 121, no. 6, pp. 233–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Monteleone, A. Kumberova, N. M. Croft, C. McKenzie, H. W. Steer, and T. T. MacDonald, “Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease,” The Journal of Clinical Investigation, vol. 108, no. 4, pp. 601–609, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Monteleone, R. Caruso, and F. Pallone, “Role of Smad7 in inflammatory bowel diseases,” World Journal of Gastroenterology, vol. 18, no. 40, pp. 5664–5668, 2012. View at Google Scholar
  21. S. P. Hussain and C. C. Harris, “Inflammation and cancer: an ancient link with novel potentials,” International Journal of Cancer, vol. 121, no. 11, pp. 2373–2380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Lu, W. Ouyang, and C. Huang, “Inflammation, a key event in cancer development,” Molecular Cancer Research, vol. 4, no. 4, pp. 221–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Rousseau, B. Chibaudel, J.-B. Bachet et al., “Stage II and stage III colon cancer: treatment advances and future directions,” Cancer Journal, vol. 16, no. 3, pp. 202–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. A. Thompson and E. W. Gerner, “Current concepts in colorectal cancer prevention,” Expert Review of Gastroenterology and Hepatology, vol. 3, no. 4, pp. 369–382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Vucenik and A. M. Shamsuddin, “Protection against cancer by dietary IP6 and inositol,” Nutrition and Cancer, vol. 55, no. 2, pp. 109–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Gu, K. Raina, C. Agarwal, and R. Agarwal, “Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells,” Molecular Carcinogenesis, vol. 49, no. 1, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Matejuk and A. Shamsuddin, “IP6 in cancer therapy: past, present and future,” Current Cancer Therapy Reviews, vol. 6, no. 1, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Liao, D. N. Seril, A. L. Yang, G. G. Lu, and G.-Y. Yang, “Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds,” Carcinogenesis, vol. 28, no. 2, pp. 446–454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kapral, J. Wawszczyk, A. Hollek et al., “Induction of the expression of genes encoding TGF-β, isoforms and their receptors by inositol hexaphosphate in human colon cancer cells,” Acta Poloniae Pharmaceutica, vol. 70, no. 2, pp. 357–363, 2013. View at Google Scholar
  31. M. Kapral, B. Parfiniewicz, B. Strzałka-Mrozik, A. Zachacz, and L. Wȩglarz, “Evaluation of the expression of transcriptional factor NF-κB induced by phytic acid in colon cancer cells,” Acta Poloniae Pharmaceutica, vol. 65, no. 6, pp. 697–702, 2008. View at Google Scholar · View at Scopus
  32. Y. S. Kim, M. R. Young, G. Bobe, N. H. Colburn, and J. A. Milner, “Bioactive food components, inflammatory targets, and cancer prevention,” Cancer Prevention Research, vol. 2, no. 3, pp. 200–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. D. Davis, “Nutritional interactions: credentialing of molecular targets for cancer prevention,” Experimental Biology and Medicine, vol. 232, no. 2, pp. 176–183, 2007. View at Google Scholar · View at Scopus
  34. J.-M. Cherng, W. Chiang, and L.-C. Chiang, “Immunomodulatory activities of edible beans and related constituents from soybean,” Food Chemistry, vol. 104, no. 2, pp. 613–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Wȩglarz, J. Wawszczyk, A. Orchel, M. Jaworska-Kik, and Z. Dzierzewicz, “Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1β,” Digestive Diseases and Sciences, vol. 52, no. 1, pp. 93–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Cholewa, B. Parfiniewicz, I. Bednarek et al., “The influence of phytic acid on TNF-α and its receptors genes' expression in colon cancer Caco-2 cells,” Acta Poloniae Pharmaceutica, vol. 65, no. 1, pp. 75–79, 2008. View at Google Scholar · View at Scopus
  37. J. Wawszczyk, M. Kapral, A. Hollek et al., “The effect of phytic acid on the expression of NF-κB, IL-6 and IL-8 in IL-1β-stimulated human colonic epithelial cells,” Acta Poloniae Pharmaceutica, vol. 69, no. 6, pp. 1313–1319, 2012. View at Google Scholar
  38. L. H. Zeuthen, L. N. Fink, and H. Frokiaer, “Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-β,” Immunology, vol. 123, no. 2, pp. 197–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Haller, C. Bode, W. P. Hammes, A. M. A. Pfeifer, E. J. Schiffrin, and S. Blum, “Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures,” Gut, vol. 47, no. 1, pp. 79–87, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Yoshioka, Y. Morimoto, H. Iwagaki et al., “Bacterial lipopolysaccharide induces transforming growth factor β and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells,” Journal of International Medical Research, vol. 29, no. 5, pp. 409–420, 2001. View at Google Scholar · View at Scopus
  41. J. van de Walle, A. Hendrickx, B. Romier, Y. Larondelle, and Y.-J. Schneider, “Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation,” Toxicology in Vitro, vol. 24, no. 5, pp. 1441–1449, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Rossol, H. Heine, U. Meusch et al., “LPS-induced cytokine production in human monocytes and macrophages,” Critical Reviews in Immunology, vol. 31, no. 5, pp. 379–446, 2011. View at Google Scholar · View at Scopus
  43. B. Bahrami, S. Macfarlane, and G. T. Macfarlane, “Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines,” Journal of Applied Microbiology, vol. 110, no. 1, pp. 353–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. I. Drygiannakis, V. Valatas, O. Sfakianaki et al., “Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis,” Journal of Crohn's and Colitis, vol. 7, no. 4, pp. 286–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. M. E. McAlindon, C. J. Hawkey, and Y. R. Mahida, “Expression of interleukin 1β and interleukin 1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease,” Gut, vol. 42, no. 2, pp. 214–219, 1998. View at Google Scholar · View at Scopus
  46. R. N. Apte and E. Voronov, “Interleukin-1 - major pleiotropic cytokine in tumor-host interactions,” Seminars in Cancer Biology, vol. 12, no. 4, pp. 277–290, 2002. View at Google Scholar
  47. G. de Crescenzo, S. Grothe, J. Zwaagstra, M. Tsang, and M. D. O'Connor-McCourt, “Real-time monitoring of the interactions of transforming growth factor-β (TGF-β) isoforms with latency-associated protein and the ectodomains of the TGF-β type II and III receptors reveals different kinetic models and stoichiometries of binding,” The Journal of Biological Chemistry, vol. 276, no. 32, pp. 29632–29643, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. B. C. Mckaig, K. Hughes, P. J. Tighe, and A. Y. R. Mahida, “Differential expression of TGF-β isoforms by normal and inflammatory bowel disease intestinal myofibroblasts,” American Journal of Physiology: Cell Physiology, vol. 282, no. 1, pp. C172–C182, 2002. View at Google Scholar · View at Scopus
  49. Y.-J. Lee, Y. Han, H.-T. Lu et al., “TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression,” Journal of Immunology, vol. 158, no. 5, pp. 2065–2075, 1997. View at Google Scholar · View at Scopus
  50. A. Di Sabatino, C. L. Jackson, K. M. Pickard et al., “Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures,” Gut, vol. 58, no. 6, pp. 777–789, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Rahal, P. Schmiedlin-Ren, J. Adler et al., “Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease,” Inflammatory Bowel Diseases, vol. 18, no. 4, pp. 613–623, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Kapral, J. Wawszczyk, M. Jurzak, A. Hollek, and L. Weglarz, “The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells,” International Journal of Colorectal Disease, vol. 27, no. 11, pp. 1419–1428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. D. W. Kamp, V. A. Israbian, A. V. Yeldandi, R. J. Panos, P. Graceffa, and S. A. Weitzman, “Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos,” Toxicologic Pathology, vol. 23, no. 6, pp. 689–695, 1995. View at Google Scholar · View at Scopus